Showing results (51-60 of 153) with videos related to
Sort By:
Pageof 16
The Journal of Experimental Zoology|January 1, 1989
Role of the mouse visceral yolk sac in nutrition: inhibition by a somatomedin inhibitorW Balkan, L S Phillips, S Goldstein, et al.Diabetes|August 1, 1986
Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in cultureT W Sadler, L S Phillips, W Balkan, et al.Science (New York, N.Y.)|January 8, 1982
Actin distribution patterns in the mouse neural tube during neurulationT W Sadler, D Greenberg, P Coughlin, et al.Teratology|April 23, 2002
Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse modelJennifer M Burgoon, Jacob Selhub, Marie Nadeau, et al.Journal of Chromatography|October 31, 1986
Reversed-phase high-performance liquid chromatographic determination of verofylline in rat serumL Shum, W J JuskoThe Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Theophylline disposition in obese ratsL Shum, W J JuskoBiopharmaceutics & Drug Disposition|November 1, 1989
Effects of obesity and ancillary variables (dialysis time, drug, albumin, and fatty acid concentrations) on theophylline serum protein bindingL Shum, W J JuskoXenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1991
Verofylline pharmacokinetics in dietary-induced obese rats: role of fat mass and protein binding in determining volume of distributionL Shum, W J JuskoAnatomy and Embryology|January 1, 1993
Serotonin and morphogenesis. Transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouseD L Shuey, T W Sadler, H Tamir, et al.Teratology|April 1, 1991
Altered visceral yolk sac function produced by a low-molecular-weight somatomedin inhibitorE S Hunter, L S Phillips, S Goldstein, et al.Pageof 16